Crossref
In pregnant people at term receiving intravenous (IV) oxytocin for labor induction or augmentation, what are the effects of continuing versus discontinuing oxytocin during active labor?
Cochrane Clinical Answers · 09.11.2026
DOI: 10.1002/cca.4878 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cochrane Clinical Answers, online erschienen am 09.11.2026. Verfasst von Ashraf Nabhan. Die Arbeit nennt 15 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Nabhan, A. (2026). In pregnant people at term receiving intravenous (IV) oxytocin for labor induction or augmentation, what are the effects of continuing versus discontinuing oxytocin during active labor?. Cochrane Clinical Answers. https://doi.org/10.1002/cca.4878
Vancouver
Nabhan A. In pregnant people at term receiving intravenous (IV) oxytocin for labor induction or augmentation, what are the effects of continuing versus discontinuing oxytocin during active labor?. Cochrane Clinical Answers. 2026. doi:10.1002/cca.4878
BibTeX
@article{Nabhan2026,
author = {Nabhan, Ashraf},
title = {In pregnant people at term receiving intravenous (IV) oxytocin for labor induction or augmentation, what are the effects of continuing versus discontinuing oxytocin during active labor?},
journal = {Cochrane Clinical Answers},
year = {2026},
doi = {10.1002/cca.4878}
}
EUVIMED